NCT06812260 2026-05-20A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLCShanghai Henlius BiotechPhase 2 Active not recruiting26 enrolled